Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
07/1981
07/28/1981CA1105925A1 Pentapeptide compositions and methods
07/28/1981CA1105923A1 Pentapeptides and methods
07/28/1981CA1105863A1 Biologically active substance
07/21/1981US4279812 Process for preparing macromolecular biologically active collagen
07/21/1981US4279810 Easily split substrates for the quantification of proteases
07/21/1981CA1105404A1 .alpha.-AMYLASE INHIBITOR FROM A STREPTOMYCETE AND PROCESS FOR ITS PREPARATION
07/21/1981CA1105382A1 Preparation of albumin
07/15/1981EP0032134A2 DNA sequences, recombinant DNA molecules and processes for producing human interferon-alpha like polypeptides
07/15/1981EP0031999A2 Antitumor protein hybrid and process for the preparation thereof
07/14/1981US4278661 Purification of interferon
07/14/1981US4278596 Analgesic pentapeptides
07/14/1981US4278594 Process for separation and isolation of AHF, von Willebrand's ristocetin cofactor (VWF:RCF) and fibronectin from blood plasma
07/14/1981US4278592 Process and apparatus for the production of sterile filtered blood clotting factors
07/09/1981WO1981001849A1 Purified human prostate antigen
07/08/1981EP0031567A2 Tetrapeptidesemicarbazide derivatives and their production and use
07/08/1981EP0031381A1 Method for the purification and analysis of interferon
07/07/1981US4277564 Preparing entomocidal products with oligosporogenic mutants of bacillus thuringiensis
07/07/1981US4277393 Radioimmunoassay method for determining calcitonin and radioactive tracer for use therein
07/01/1981EP0031303A2 Cyclooctapeptides and pharmaceutical preparations thereof, as well as their preparation process and their use
07/01/1981EP0031221A1 Cyclic peptide nuclei
06/1981
06/30/1981US4276282 Interferon and preparations containing interferon
06/30/1981US4276206 Generally applicable method of making immunosuppressive agents
06/30/1981US4276140 Ion exchanging, desalting
06/30/1981CA1104127A1 Method for preparing pyrogen free collagen
06/25/1981WO1981001709A1 Polypeptides
06/24/1981EP0030920A2 Acyl peptides and pharmaceutical preparations thereof, as well as their manufacture and use
06/24/1981EP0030848A2 Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
06/24/1981EP0030847A2 Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
06/24/1981EP0030846A2 Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
06/24/1981EP0030845A2 Pharmacologically active peptides, their preparation and pharmaceutical compositions containing them
06/24/1981EP0030815A2 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody
06/24/1981EP0030814A2 Hybrid cell line for producing monoclonal antibody to a human early thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/24/1981EP0030728A2 Feline leukemia vaccine
06/23/1981US4275056 HGI-Glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, process for preparing same and leukopenia curative containing same
06/23/1981US4275001 Process for the manufacture of LH-RH and LH-RH analogs using Glu-His(DnP)-OH
06/17/1981EP0030496A1 Thiolated polypeptidic compound coming from a fragment of tetanic toxine, process for obtaining it and its applications
06/17/1981EP0030450A2 Hybrid cell line for producing complement-fixing, monoclonal antibody to human suppressor T cells, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/17/1981EP0030449A2 Hybrid cell line for producing monoclonal antibody to human thymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses and pharmaceutical compositions comprising this antibody
06/17/1981EP0030363A2 Process for obtaining alpha-2-SB-glycoprotein
06/16/1981US4273865 Insolubilized biochemical materials
06/16/1981US4273705 Ultrasonic frequency sound waves
06/16/1981US4273704 N-Adamantane-substituted tetrapeptide amides
06/16/1981US4273703 Interferon product and process for its preparation
06/16/1981CA1103156A1 Method of producing tumor antibodies
06/11/1981WO1981001517A1 Process for isolating and purifying a fraction capable of inhibiting mutagenicity of a mutagenic material from burdock juice
06/10/1981EP0030094A1 Calcium enhanced interferon production process
06/09/1981US4272523 Fractionating citrate-stabilized plasma
06/09/1981US4272521 Purified immune serum globulin
06/09/1981US4272433 Polypeptides, protein carriers
06/03/1981EP0029659A2 Vasopressin analogs, processes for their production and a method of treating mammals
06/03/1981EP0029579A1 Polypeptides, processes for their production, pharmaceutical compositions comprising said polypeptides and their use
06/02/1981US4271152 Psycho-pharmacological peptides
06/02/1981US4271151 Protein-bound polysaccharides
06/02/1981US4271070 Chemically-modified fiber collagen hemostatic agents
06/02/1981US4271069 Beta-hCG preparation and method
06/02/1981US4271067 Glycopeptide
06/02/1981CA1102315A1 Somatostatin analogs and intermediates thereto
06/02/1981CA1102314A1 Peptides which effect release of hormones
06/02/1981CA1102313A1 Somatostatin analogs with dissociated biological activities
06/02/1981CA1102312A1 ANALOGS OF .beta..SUB.H-ENDORPHIN AND PROCESS FOR THE PREPARATION THEREOF
05/1981
05/27/1981EP0029310A1 Cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them
05/27/1981EP0029300A1 Polypeptides, antisera containing them and methods of their use
05/27/1981EP0029191A1 Protein PP 11, process for its isolation and its use
05/26/1981US4269825 New glycoprotein and process for isolating it
05/26/1981US4269765 Immune serum for diagnosis of cancer and preparation thereof
05/26/1981US4269605 Method and kit for separation of glycoproteins
05/26/1981CA1101847A1 Process for the concentration of a placenta-specific glycoprotein
05/26/1981CA1101844A1 Polypeptide
05/26/1981CA1101842A1 THYMOSIN .alpha.1
05/20/1981EP0028795A2 Valproic acid conjugates and antibodies thereto
05/20/1981EP0028627A1 Process for producing polypeptide alpha-thymosine and derivatives therefrom.
05/19/1981CA1101332A1 Simplified method for preparation of high yield, high purity factor viii concentrate
05/13/1981EP0028567A2 Method of preparing hepatitis B surface antigen
05/13/1981EP0028489A1 Enzyme derivatives, and their preparation
05/13/1981EP0028332A1 Beta-galactosyl-umbelliferone-labeled protein and polypeptide conjugates, and N-substituted 7-beta-galactosylcumarin-3-carboxamides
05/13/1981EP0028246A1 Controlled protein fractionation
05/12/1981US4267234 Polyglutaraldehyde synthesis and protein bonding substrates
05/12/1981US4267101 Process for obtaining human relaxin from fetal membranes
05/12/1981CA1100947A1 Psychopharmacologically active peptides and peptide derivatives, and the use thereof
05/12/1981CA1100876A1 Use of a nitrogen-containing polysaccharide for promoting drug-sensitivity of bacteria resistant to antibiotics
05/06/1981EP0028033A2 Double-stranded DNA which codes for a polypeptide with human fibroblast interferon activity, cloned DNA, recombinant plasmid containing the DNA and microorganism containing the recombinant plasmid
05/06/1981EP0028016A2 Process for purifying interferon
05/06/1981EP0027793A1 High purity animal interferons
05/05/1981US4266024 Process for the production of human interferon
05/05/1981US4265884 Therapeutically active polypeptides or acid addition salts thereof and a process for producing such compounds
05/05/1981US4265881 Plasminogen-activating substance and the preparation and use of such substance
05/05/1981US4265808 Pharmacologically active peptides
05/05/1981CA1100486A1 Method for determining calcitonin
05/05/1981CA1100485A1 Somatostatin analogs and intermediates thereto
04/1981
04/30/1981WO1981001145A1 Hydrolytic enzyme-activatible pro-drugs
04/30/1981WO1981001101A1 Improvements in or relating to vaccines
04/29/1981EP0027710A1 Antibiotic substances, a process for the preparation and compositions thereof; a new strain of Staphylococcus epidermidis which produces the said antibiotic substance and compositions thereof
04/29/1981EP0027664A1 Use of the PP5 protein, its derivatives or the antibodies directed against that protein in contraception or in disruption of pregnancy
04/29/1981EP0027631A1 Flavin adenine dinucleotide-labeled protein and polypeptide conjugates
04/29/1981EP0027573A2 Method of stabilizing interferon and composition containing it
04/29/1981EP0027533A1 Photographic materials, process for their production, their use and the use of gelatines
04/29/1981EP0027514A1 Antitumor substance and its production
04/28/1981US4264731 DNA Joining method
04/28/1981US4264589 Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
04/28/1981US4264587 Vaccine for preventing persistent feline leukemia viremia in cats